In the spotlight

Cinclus Pharma Partners with Zentiva to Commercialize Linaprazan Glurate in Europe

22 May 2025

Cinclus Pharma establishes a strategic alliance and licensing agreement with Zentiva, a leading European pharmaceutical company, for the commercialization and manufacturing of linaprazan glurate in Europe.

Read more

Presentation at the Nordea Equities Healthcare Seminar

8 May 2025

Christer Ahlberg, CEO of Cinclus Pharma, gave a presentation today at the Nordea Equities Healthcare Seminar, where he spoke about the company's ongoing clinical development and strategic direction.

Read more

Cinclus Pharma participates at Biostock Global Forum in Lund, Sweden, May 21.

8 May 2025

Cinclus Pharma participates at Biostock Global Forum in Lund, Sweden, May 21.

Read more